Ivosidenib is made for treating AML when it comes back or doesn’t respond to treatment, especially in folks with IDH1 mutations. It’s like a superhero for the IDH1 enzyme, trying to keep cancer cells from multiplying.
You get it as 250 mg tablets, but you take 500 mg every day, and you swallow them, no big deal. Each bottle has a total of 60 of these tablets, no less.
